Comparison between CHA2DS2-VASc and the new R2CHADS2 and ATRIA scores at predicting thromboembolic event in non-anticoagulated and anticoagulated patients with non-valvular atrial fibrillation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2261
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Comparison between CHA2DS2-VASc and the new R2CHADS2 and ATRIA scores at predicting thromboembolic event in non-anticoagulated and anticoagulated patients with non-valvular atrial fibrillation ; volume:15 ; number:1 ; day:19 ; month:11 ; year:2015 ; pages:1-7 ; date:12.2015
BMC cardiovascular disorders ; 15, Heft 1 (19.11.2015), 1-7, 12.2015
- Urheber
-
Abumuaileq, Rami Riziq-Yousef
Abu-Assi, Emad
López-López, Andrea
Raposeiras-Roubin, Sergio
Rodríguez-Mañero, Moisés
Martínez-Sande, Luis
García-Seara, Javier
Fernandez-López, Xesús Alberte
Peña-Gil, Carlos
González-Juanatey, Jose Ramón
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12872-015-0149-3
- URN
-
urn:nbn:de:101:1-2019080819101447772530
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Abumuaileq, Rami Riziq-Yousef
- Abu-Assi, Emad
- López-López, Andrea
- Raposeiras-Roubin, Sergio
- Rodríguez-Mañero, Moisés
- Martínez-Sande, Luis
- García-Seara, Javier
- Fernandez-López, Xesús Alberte
- Peña-Gil, Carlos
- González-Juanatey, Jose Ramón
- SpringerLink (Online service)
Ähnliche Objekte (12)
Ischemic stroke risk factors not included in the CHADS-VASC score in patients with non-valvular atrial fibrillation
Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
Morphology and location of thrombus and sludge in patients with non-valvular atrial fibrillation
Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prior ischemic strokes are non-inferior for predicting future ischemic strokes than CHA2DS2-VASc score in hemodialysis patients with non-valvular atrial fibrillation
Predicting a decrease in left atrial appendage flow velocity using left atrial diameter and CHA2DS2-VASc score in patients with non-valvular atrial fibrillation
Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity
Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation
Anticoagulation for non-valvular atrial aibrillation – towards a new beginning with ximelagatran
Ischemic stroke risk factors not included in the CHADS-VASC score in patients with non-valvular atrial fibrillation
Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
Morphology and location of thrombus and sludge in patients with non-valvular atrial fibrillation
Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prior ischemic strokes are non-inferior for predicting future ischemic strokes than CHA2DS2-VASc score in hemodialysis patients with non-valvular atrial fibrillation
Predicting a decrease in left atrial appendage flow velocity using left atrial diameter and CHA2DS2-VASc score in patients with non-valvular atrial fibrillation
Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity
Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation
Anticoagulation for non-valvular atrial aibrillation – towards a new beginning with ximelagatran
Ischemic stroke risk factors not included in the CHADS-VASC score in patients with non-valvular atrial fibrillation
Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
Morphology and location of thrombus and sludge in patients with non-valvular atrial fibrillation
Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prior ischemic strokes are non-inferior for predicting future ischemic strokes than CHA2DS2-VASc score in hemodialysis patients with non-valvular atrial fibrillation
Predicting a decrease in left atrial appendage flow velocity using left atrial diameter and CHA2DS2-VASc score in patients with non-valvular atrial fibrillation
Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity
Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation